Author:
Tsuburaya Akira,Sakamoto Junichi,Morita Satoshi,Kodera Yasuhiro,Kobayashi Michiya,Miyashita Yumi,Macdonald John S.
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference12 articles.
1. Miyashiro I, Furukawa H, Sasako M, Yamamoto S, Nashimoto A, Nakajima T, et al. No survival benefit with adjuvant chemotherapy for serosa-positive gastric cancer. Randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil in serosa-positive gastric cancer. Japan Clinical Oncology Group 9206-2. Proc ASCO-GI 2005; 84 (abstr 4).
2. Kinoshita T, Nakajima T, Ohashi Y, National Surgical Adjuvant Study Group for Gastric Cancer (N-SAS-GC). Adjuvant chemotherapy with uracil-tegafur (UFT) for serosa negative advanced gastric cancer: results of a randomized trial by national surgical adjuvant study of gastric cancer. Proc Am Soc Clin Oncol2005;23:313.
3. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med2001;345:725–30.
4. Ohta K. Present status of treatment for stomach cancer in Japan (from the questionnaire). Chiryou2000;82:1782–3.
5. Yamada Y, Shirao K, Ohtsu A, Boku N, Hyodo I, Saitoh H, et al. Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Ann Oncol2001;12:1133–7.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献